News | EP Lab

May 14, 2021 — Abbott is recalling a subset of Assurity and Endurity pacemakers built using specific manufacturing ...

Home May 14, 2021
Home
News | Coronavirus (COVID-19)

May 13, 2021 — The Centers for Disease Control and Prevention (CDC) just released a new statement relaxing the ...

Home May 13, 2021
Home
Explaining the Emory TMVR angle. Discordance between mitral annular centerline (yellow lines) and valve orientation imposed by guidewire position within the LV apex (red dashed lines). (B) Valve intrinsic angle (α) is determined by external skirt height. (C) When annular-apical “Emory” angle (red curves) exceeds α (blue curve), annular skirt apposition is not possible, causing PVL (red arrows). (D) The valve is oriented perpendicular to the annual plane using an exteriorized apical guidewire.
Feature | Structural Heart | By Dave Fornell, Editor

The mitral valve anatomy is extremely complex, which has caused many challenges for transcatheter mitral valve ...

Home May 13, 2021
Home
Videos | Structural Heart

Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, and principle investigator ...

Home May 13, 2021
Home
News | Coronavirus (COVID-19)

May 13, 2021 — Estimates of excess deaths, defined as the number of persons who have died from all causes, above the ...

Home May 13, 2021
Home
News | Pediatric Cardiology

May 13, 2021 — PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve ...

Home May 13, 2021
Home
News | Cath Lab

May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has ...

Home May 12, 2021
Home
News | Cardiac Imaging

May 12, 2021 — According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 ...

Home May 12, 2021
Home
News | Endovascular Aortic Repair

May 12, 2021 — Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a ...

Home May 12, 2021
Home
News | EP Lab

May 12, 2021 — Galaxy Medical and Japan Lifeline announced an exclusive distribution agreement for the Alpha1 ablation ...

Home May 12, 2021
Home
News | Artificial Intelligence

May 12, 2021 — HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced that the National ...

Home May 12, 2021
Home
The BioCardia cardiac stem cell CardiAMP trial is a Phase III study looking at the efficacy of using stem cells to improve heart function in heart failure patients. It is the first trial for this technology to reach Phase III trial.
Feature | Stem Cell Therapies | By Simon H. Stertzer, M.D.

Heart failure remains an unheralded global pandemic, costing society billions of dollars each year.[1,2] Projections ...

Home May 11, 2021
Home
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Home
News | Heart Failure

May 11, 2021 — Patients hospitalized with COVID-19 may be at risk of developing heart failure even if they do not have a ...

Home May 11, 2021
Home
Videos | Structural Heart

Philippe Géneréux, M.D., director of the structural heart program at Atlantic Health System’s Morristown Medical Center ...

Home May 10, 2021
Home
Subscribe Now